Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

A Randomized Trial of Distal Diuretics versus Dietary Sodium Restriction for Hypertension in Chronic Kidney Disease.

Bovée DM, Visser WJ, Middel I, De Mik-van Egmond A, Greupink R, Masereeuw R, Russel FGM, Danser AHJ, Zietse R, Hoorn EJ.

J Am Soc Nephrol. 2020 Jan 29. pii: ASN.2019090905. doi: 10.1681/ASN.2019090905. [Epub ahead of print]

PMID:
31996411
2.

Targeting angiotensinogen with RNA-based therapeutics.

Ren L, Colafella KMM, Bovée DM, Uijl E, Danser AHJ.

Curr Opin Nephrol Hypertens. 2020 Mar;29(2):180-189. doi: 10.1097/MNH.0000000000000586.

PMID:
31895165
3.

The renin-angiotensin-aldosterone system and its therapeutic targets.

Mirabito Colafella KM, Bovée DM, Danser AHJ.

Exp Eye Res. 2019 Sep;186:107680. doi: 10.1016/j.exer.2019.05.020. Epub 2019 May 23. Review.

PMID:
31129252
4.

Tubular (Pro)renin Release.

Sun Y, Bovée DM, Danser AHJ.

Hypertension. 2019 Jul;74(1):26-28. doi: 10.1161/HYPERTENSIONAHA.119.12977. Epub 2019 May 13. No abstract available.

PMID:
31079536
5.

Increased Urinary Extracellular Vesicle Sodium Transporters in Cushing Syndrome With Hypertension.

Salih M, Bovée DM, van der Lubbe N, Danser AHJ, Zietse R, Feelders RA, Hoorn EJ.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2583-2591. doi: 10.1210/jc.2018-00065.

PMID:
29726949
6.

Urinary renin-angiotensin markers in polycystic kidney disease.

Salih M, Bovée DM, Roksnoer LCW, Casteleijn NF, Bakker SJL, Gansevoort RT, Zietse R, Danser AHJ, Hoorn EJ.

Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F874-F881. doi: 10.1152/ajprenal.00209.2017. Epub 2017 Jul 26.

Supplemental Content

Loading ...
Support Center